Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Primary Care
Do you recommend using topical metronidazole for managing odor related to pressure ulcers?
Do you have concerns about toxicity or antibiotic resistance with this approach?
Related Questions
Do you use oral fosfomycin as a treatment option for uncomplicated cystitis due to ESBL producing E coli?
In a patient with vaginal itching and a vaginal swab with a positive Candida glabrata NAAT, what is your first-line therapy?
Do you recommend boric acid for patients with recurrent candida vulvovaginitis?
What is your approach to the use of Paxlovid for patients with risk factors for severe Covid-19 infection but who have received SARS-CoV-2 vaccines in light of the EPIC-SR trial findings?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
Do you routinely offer suppressive antibiotics to patients with a prosthetic joint infection when surgery is delayed for months?
For how long would you treat Klebsiella aerogenes folliculitis of the face manifesting as a cystic lesion?
What duration of therapy do you recommend for patients with a vascular graft infection in which the graft has been removed and another graft placed in the infected space?
Do you adhere to the standard 5-day minimum treatment duration for community-acquired pneumonia, or have you used shorter courses for certain low-risk patients?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?